State Board of Administration of Florida Retirement System Sells 5,210 Shares of Hologic, Inc. (HOLX)

State Board of Administration of Florida Retirement System trimmed its position in Hologic, Inc. (NASDAQ:HOLX) by 1.3% during the 1st quarter, HoldingsChannel.com reports. The firm owned 396,927 shares of the medical equipment provider’s stock after selling 5,210 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Hologic were worth $19,211,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. Oregon Public Employees Retirement Fund grew its stake in shares of Hologic by 3,960.1% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,222,766 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 1,192,649 shares during the last quarter. Horan Capital Advisors LLC. bought a new position in shares of Hologic during the first quarter valued at $33,000. Lindbrook Capital LLC bought a new position in shares of Hologic during the fourth quarter valued at $36,000. Essex Savings Bank bought a new position in shares of Hologic during the fourth quarter valued at $37,000. Finally, First Interstate Bank bought a new position in shares of Hologic during the first quarter valued at $40,000. 97.84% of the stock is currently owned by institutional investors.

In other Hologic news, insider Benjamin Jordan Cohn sold 6,830 shares of the stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $46.70, for a total value of $318,961.00. Following the transaction, the insider now owns 22,002 shares of the company’s stock, valued at $1,027,493.40. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Sally Crawford sold 12,306 shares of the stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $47.61, for a total value of $585,888.66. Following the completion of the transaction, the director now directly owns 168,886 shares in the company, valued at approximately $8,040,662.46. The disclosure for this sale can be found here. In the last three months, insiders sold 23,378 shares of company stock worth $1,105,836. 0.90% of the stock is owned by corporate insiders.

HOLX stock opened at $44.91 on Wednesday. Hologic, Inc. has a fifty-two week low of $37.47 and a fifty-two week high of $48.82. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.02 and a current ratio of 1.45. The stock has a market capitalization of $11.96 billion, a price-to-earnings ratio of 20.14, a PEG ratio of 2.06 and a beta of 0.71.

Hologic (NASDAQ:HOLX) last posted its earnings results on Wednesday, May 1st. The medical equipment provider reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.57 by $0.01. Hologic had a positive return on equity of 26.73% and a negative net margin of 0.32%. The company had revenue of $818.40 million for the quarter, compared to the consensus estimate of $806.99 million. During the same quarter in the prior year, the company earned $0.53 earnings per share. Hologic’s revenue was up 3.7% on a year-over-year basis. On average, equities analysts predict that Hologic, Inc. will post 2.42 earnings per share for the current year.

A number of brokerages have recently issued reports on HOLX. Needham & Company LLC reaffirmed a “buy” rating and set a $50.00 price target on shares of Hologic in a report on Tuesday, April 2nd. Zacks Investment Research raised Hologic from a “sell” rating to a “hold” rating in a report on Tuesday, April 23rd. BidaskClub downgraded Hologic from a “hold” rating to a “sell” rating in a report on Tuesday, April 23rd. BTIG Research reaffirmed a “buy” rating and set a $52.00 price target on shares of Hologic in a report on Thursday, May 2nd. Finally, Piper Jaffray Companies upped their price target on Hologic to $49.00 and gave the company an “overweight” rating in a report on Thursday, January 31st. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company’s stock. Hologic currently has an average rating of “Hold” and an average target price of $45.41.

ILLEGAL ACTIVITY NOTICE: This news story was posted by Slater Sentinel and is the sole property of of Slater Sentinel. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://slatersentinel.com/news/2019/05/15/state-board-of-administration-of-florida-retirement-system-sells-5210-shares-of-hologic-inc-holx.html.

About Hologic

Hologic, Inc, a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.

Recommended Story: Marijuana Stocks

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.